Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Theralase Technologies Inc (TLT.VN)

Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 41,129
  • Shares Outstanding, K 257,058
  • Annual Sales, $ 1,033 K
  • Annual Income, $ -4,256 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta -0.45
  • Price/Sales 40.29
  • Price/Cash Flow N/A
  • Price/Book 37.64
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.02
  • Most Recent Earnings $0.00 on 11/10/25
  • Next Earnings Date 11/26/25
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING:

    TSX Medical Devices

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.145 +6.90%
on 12/15/25
0.165 -6.06%
on 12/08/25
unch (unch)
since 11/28/25
3-Month
0.145 +6.90%
on 12/15/25
0.220 -29.55%
on 10/23/25
-0.035 (-18.42%)
since 09/30/25
52-Week
0.145 +6.90%
on 12/15/25
0.335 -53.73%
on 01/06/25
-0.095 (-38.00%)
since 12/30/24

Most Recent Stories

More News
Theralase(R) Closes $1.3 M Non-Brokered Private Placement

Toronto, Ontario--(Newsfile Corp. - December 23, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering...

TLT.VN : 0.155 (-3.13%)
TLTFF : 0.1140 (-3.55%)
Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing

Toronto, Ontario--(Newsfile Corp. - December 12, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering...

TLT.VN : 0.155 (-3.13%)
TLTFF : 0.1140 (-3.55%)
Theralase(R) Announces Brokered LIFE Financing to Further Advance its Phase II Non-Muscle Invasive Bladder Cancer Clinical Study

Toronto, Ontario--(Newsfile Corp. - November 24, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light,...

TLT.VN : 0.155 (-3.13%)
Theralase(R) Investor Conference Call Reminder

Theralase(R) Reminds Investors of Conference Call to Provide Update on Study II Interim Data Demonstrating 64.3% Complete ResponseToronto, Ontario--(Newsfile Corp. - November 17, 2025) - Theralase® Technologies...

TLT.VN : 0.155 (-3.13%)
TLTFF : 0.1140 (-3.55%)
Theralase(R) Releases 3Q2025 Financial Statements

Toronto, Ontario--(Newsfile Corp. - November 10, 2025) - Theralase® Technologies Inc. (TSXV:TLT) (OTCQB:TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical pioneering light, radiation,...

TLT.VN : 0.155 (-3.13%)
TLTFF : 0.1140 (-3.55%)
Theralase(R) Demonstrates Effectiveness of X-Ray-Activated Drug

Toronto, Ontario--(Newsfile Corp. - November 3, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light,...

TLT.VN : 0.155 (-3.13%)
TLTFF : 0.1140 (-3.55%)
Independent Research Demonstrates Ruvidar(R) Effective in the Destruction of Herpes Simplex Virus

Toronto, Ontario--(Newsfile Corp. - September 24, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering...

TLT.VN : 0.155 (-3.13%)
TLTFF : 0.1140 (-3.55%)
Theralase(R) Extends Warrants

Toronto, Ontario--(Newsfile Corp. - August 29, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light,...

TLT.VN : 0.155 (-3.13%)
TLTFF : 0.1140 (-3.55%)
Theralase(R) Releases 2Q2025 Financial Statements

Toronto, Ontario--(Newsfile Corp. - August 26, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical pioneering light, radiation,...

TLT.VN : 0.155 (-3.13%)
TLTFF : 0.1140 (-3.55%)
Theralase(R) Closes Non-Brokered Private Placement

Toronto, Ontario--(Newsfile Corp. - July 28, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light,...

TLT.VN : 0.155 (-3.13%)
TLTFF : 0.1140 (-3.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Theralase Technologies Inc brings CLT to patients and personalized ACT to patients based on individual tissue characteristics. It is two separate reportable operating divisions; the Drug Division and the Device Division. The Drug Division develops patented, and patent pending drugs, called Photo Dynamic...

See More

Key Turning Points

3rd Resistance Point 0.167
2nd Resistance Point 0.163
1st Resistance Point 0.162
Last Price 0.155
1st Support Level 0.157
2nd Support Level 0.153
3rd Support Level 0.152

See More

52-Week High 0.335
Fibonacci 61.8% 0.262
Fibonacci 50% 0.240
Fibonacci 38.2% 0.218
Last Price 0.155
52-Week Low 0.145

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar